Vident Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Sell |
49,760
-1,386
| -3% | -$95.7K | 0.04% | 362 |
|
|
2025
Q1 | $3.55M | Buy |
51,146
+9,685
| +23% | +$673K | 0.05% | 310 |
|
|
2024
Q4 | $3.57M | Sell |
41,461
-1,555
| -4% | -$134K | 0.06% | 282 |
|
|
2024
Q3 | $5.12M | Buy |
43,016
+7,049
| +20% | +$839K | 0.13% | 153 |
|
|
2024
Q2 | $5.13M | Buy |
35,967
+4,445
| +14% | +$634K | 0.14% | 140 |
|
|
2024
Q1 | $4.05M | Buy |
31,522
+1,258
| +4% | +$162K | 0.08% | 244 |
|
|
2023
Q4 | $3.13M | Sell |
30,264
-447
| -1% | -$46.2K | 0.08% | 275 |
|
|
2023
Q3 | $2.79M | Buy |
+30,711
| New | +$2.79M | 0.09% | 244 |
|